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Zain Hashmi is a three-year-old
little boy from northern England
with big brown eyes and a fatal
disease, beta thalassaemia major.
As his bone marrow is unable to
produce sufficient numbers of red
blood cells, he needs regular
transfusions and is unlikely to
survive for long unless
transplanted with suitable stem
cells. These could come from the
bone marrow of a donor with
matching tissue type, but neither
in his family of seven nor in the
national donors databases could 
a match be found. They could 
also come from the umbilical 
cord of a sibling yet to be
conceived, if the baby has the
matching tissue type. 
As Zain’s parents have got five
children already and feel that time
is running out for trying the natural
way, they applied for permission
to use in vitro fertilization (IVF)
combined with pre-implantation
genetic diagnosis (PGD) to make
sure that their sixth child will not
only be free of the disease, but
also have the stem cells that can
save Zain’s life. 
In Britain, sensitive bioethical
issues like this one are decided by
the Human Fertilization and
Embryology Authority
(www.hfea.gov.uk) chaired by
Ruth Deech of Oxford University.
Britain is one of the leading
countries in developing controls
on new embryo research. The
HFEA is responsible for licensing
any research and any breaches
constitute a criminal offence. In
the US, for example, controls on
federal funding for embryo
research are in place, but private
companies funding their own work
are entirely without regulation.
Decisions by the HFEA therefore
carry more weight than might
otherwise be the case. And on
December 13th last year, the
HFEA ruled that in principle PGD
may be used to create a life-
saving sibling for a seriously ill
child, but that a licence committee
would have to approve every case
individually on its merits, following
a set of very stringent conditions.
Ruth Deech said: “Where PGD is
already being undertaken, we can
see how the use of tissue typing
to save the life of a sibling could
be justified. We would see this
happening only in very rare
circumstances and under strict
controls.” These include that all
other possibilities have been
exhausted, and that the parents
receive counselling on the ethical
implications. The authority strictly
ruled out similar procedures if 
the tissue were to benefit one of
the parents.
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Apart from the knee-jerk
reaction of the anti-abortionist
group “Life” who felt that being
born into a loving family as a life-
saviour for one’s brother “could
be a terrible burden for any person
to shoulder”, and the misleading
“designer baby” headlines, there
was little doubt that this general
decision was well-considered.
Still, the authority took another
nine weeks to decide on the
individual case of Zain Hashmi,
possibly in an attempt to let any
fundamentalist fury exhaust itself
before coming to the crunch point
of a case that some might
consider a dangerous precedent
for other, less defendable ones. 
On February 22 the HFEA gave
the go-ahead for the Hashmi
family. They will now be free to
have their IVF / PGD treatment at
the Care fertility clinic in
Nottingham, although the samples
will be sent to the US for the
diagnostic part of the procedure.
Coincidentally, a baby girl whose
parents underwent the same
procedure for the benefit of a
sibling with leukaemia, but
travelled to the US to avoid having
to wait for the HFEA’s decision,
was born in a British hospital a
week earlier. 
Reactions in the British press
were generally positive, with the
predictable opposition from 
Life’s spokesman Peter Garrett
and some concerns raised by
church bodies. Meanwhile, half a
dozen other British couples with
similar problems are said to be
queuing to have their cases
considered. Apart from the
Nottingham clinic, a London
hospital is also planning to offer
this treatment.
However, Deech emphasised
the planned controls on the
procedure. A child born after the
genetic diagnosis would have the
same protection as any other child
being considered for further
transplants, such as bone marrow
donation, she said. “The wishes of
the parent alone would be
insufficient in deciding whether or
not such a donation could be
made,” a spokesperson said.
Dr Simon Fishel at the
Nottingham hospital said: “It is
always difficult to reassure 
people against bad practice and
abuse. Certainly in this country 
the regulations will assure that 
this will not take place. I think 
it is a beneficial procedure and it
will be used carefully and
guardedly.”
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The British Human Fertilization and Embryology Authority has for the
first time allowed pre-implantation diagnostics to be used for the
benefit not only of the unborn child but also of a seriously ill sibling
whose life it may save. Michael Gross reports.
